Outcome of Ankle Fracture Treated with Primary Tibiotalocalcaneal Nail
Research type
Research Study
Full title
Outcomes of Ankle Fractures Treated with Primary Retrograde Tibiotalocalcaneal (TTC) Intramedullary Nail in a Major Trauma Centre
IRAS ID
253091
Contact name
Andrew Riddick
Contact email
Sponsor organisation
North Bristol NHS Trust, Research & Innovation
Duration of Study in the UK
2 years, 4 months, 1 days
Research summary
Our research trial aims to answer the question of whether the functional and quality of life outcomes of ankle fractures treated with a primary tibiotalocalcaneal nail, a metal rod passed through the bottom of the heel up into the shin bone to hold the broken bone ends, is a viable option for patients who are deemed not suitable for fixation with plate and screws or in a plaster cast. Patients who sustain ankle fractures present with a plethora of comorbidities, mobility issues and age groups. Certain groups of patients require a low risk, weight bearing method of operative management to help with pain and give them function. We aim to see whether the use of the tibiotalocalcaneal nail is a suitable option and a certain category of patient. Any patient who has undergone a primary tibiotalocalcaneal nail for treatment of an ankle fracture will be included in this trial. The trial will be undertaken at one site, which is a high volume major trauma centre. We anticipate the trial to run over 18-24 months, recruiting 60 patients with a month follow up of outcomes and any complications.
REC name
South Central - Berkshire Research Ethics Committee
REC reference
19/SC/0598
Date of REC Opinion
10 Dec 2019
REC opinion
Favourable Opinion